Literature DB >> 27718082

Concentration of Glial Cell Line-Derived Neurotrophic Factor Positively Correlates with Symptoms in Functional Dyspepsia.

Fumio Tanaka1,2, Kazunari Tominaga3, Yoshiko Fujikawa1,4, Yasuaki Nagami1, Noriko Kamata1, Hirokazu Yamagami1, Tetsuya Tanigawa1, Masatsugu Shiba1, Toshio Watanabe1, Yasuhiro Fujiwara1, Tetsuo Arakawa1.   

Abstract

BACKGROUND: In patients with functional dyspepsia (FD), mild duodenal inflammation correlates with increased mucosal permeability. Enteric glial cells can produce glial cell line-derived neurotrophic factor (GDNF) to repair disrupted epithelial barrier function. AIMS: We examined the role of duodenal GDNF in FD pathophysiology and its association with dyspeptic symptoms.
METHODS: Duodenal biopsies taken from FD patients and control subjects were used for analysis. GDNF protein expression and localization were examined. Cellular infiltration of eosinophils and mast cells was measured. We also examined the intercellular space between the adjacent epithelial cells at the apical junction complex using transmission electron microscopy.
RESULTS: In FD patients, expression of GDNF protein was significantly increased compared with controls, 107.3 (95.3-136.7) versus 49.3 (38.0-72.6) pg/mg protein (median (interquartile range), p = 0.006), respectively. GDNF was localized in enteric glial cells, eosinophils, and epithelial cells. The number of eosinophils was significantly greater in FD patients than in controls, 1039 (923-1181) versus 553 (479-598) cells/mm2 (p = 0.021), respectively. The intercellular space was dilated at the adherent junction in FD patients compared to control patients, 32.4 (29.8-34.8) versus 22.0 (19.9-26.1) nm (p = 0.002), respectively. Intercellular distance positively correlated with the frequency of postprandial fullness and early satiation (p = 0.001, r = 0.837 and p = 0.009, r = 0.693, respectively). Expression of GDNF correlated with epigastric burning (p = 0.041, r = 0.552).
CONCLUSIONS: Increased expression of duodenal GDNF might be involved in FD pathophysiology and symptom perception.

Entities:  

Keywords:  Dyspepsia; Enteric nervous system; Glial cell line-derived neurotrophic factor; Upper gastrointestinal tract

Mesh:

Substances:

Year:  2016        PMID: 27718082     DOI: 10.1007/s10620-016-4329-5

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  22 in total

1.  Perfectionism underlying psychological background correlated with the symptoms of functional dyspepsia.

Authors:  Masahiro Ochi; Kazunari Tominaga; Toshiya Iketani; Kaori Kadouchi; Tetsuya Tanigawa; Masatsugu Shiba; Toshio Watanabe; Yasuhiro Fujiwara; Nobuhide Oshitani; Kazuhide Higuchi; Nobuo Kiriike; Tetsuo Arakawa
Journal:  J Gastroenterol       Date:  2008-09-20       Impact factor: 7.527

Review 2.  The digestive neuronal-glial-epithelial unit: a new actor in gut health and disease.

Authors:  Michel Neunlist; Laurianne Van Landeghem; Maxime M Mahé; Pascal Derkinderen; Stanislas Bruley des Varannes; Malvyne Rolli-Derkinderen
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-11-20       Impact factor: 46.802

3.  Structural changes in gastric glial cells and delayed gastric emptying as responses to early life stress and acute adulthood stress in rats.

Authors:  Kazunari Tominaga; Yoshiko Fujikawa; Fumio Tanaka; Noriko Kamata; Hirokazu Yamagami; Tetsuya Tanigawa; Toshio Watanabe; Yasuhiro Fujiwara; Tetsuo Arakawa
Journal:  Life Sci       Date:  2016-02-10       Impact factor: 5.037

4.  NIH Image to ImageJ: 25 years of image analysis.

Authors:  Caroline A Schneider; Wayne S Rasband; Kevin W Eliceiri
Journal:  Nat Methods       Date:  2012-07       Impact factor: 28.547

Review 5.  Functional gastroduodenal disorders.

Authors:  Jan Tack; Nicholas J Talley; Michael Camilleri; Gerald Holtmann; Pinjin Hu; Juan-R Malagelada; Vincenzo Stanghellini
Journal:  Gastroenterology       Date:  2006-04       Impact factor: 22.682

6.  Glial-derived neurotrophic factor regulates intestinal epithelial barrier function and inflammation and is therapeutic for murine colitis.

Authors:  Dei Kui Zhang; Fu Qian He; Tian Ke Li; Xue Hua Pang; De Jun Cui; Qin Xie; Xiao Li Huang; Hua Tian Gan
Journal:  J Pathol       Date:  2010-10       Impact factor: 7.996

7.  Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators.

Authors:  T Piche; G Barbara; P Aubert; S Bruley des Varannes; R Dainese; J L Nano; C Cremon; V Stanghellini; R De Giorgio; J P Galmiche; M Neunlist
Journal:  Gut       Date:  2008-09-29       Impact factor: 23.059

8.  Responses to gastric distension in functional dyspepsia.

Authors:  G A Salet; M Samsom; J M Roelofs; G P van Berge Henegouwen; A J Smout; L M Akkermans
Journal:  Gut       Date:  1998-06       Impact factor: 23.059

9.  Concurrent assessment of reservoir and emptying of the stomach for dyspepsia patients.

Authors:  Kazunari Tominaga; Kazuhide Higuchi; Masahiro Ochi; Kaori Kadouchi; Etsushi Kawamura; Tetsuya Tanigawa; Masatsugu Shiba; Toshio Watanabe; Yasuhiro Fujiwara; Nobuhide Oshitani; Susumu Shiomi; Tetsuo Arakawa
Journal:  Hepatogastroenterology       Date:  2008 Mar-Apr

10.  GDNF protects enteric glia from apoptosis: evidence for an autocrine loop.

Authors:  Martin Steinkamp; Heike Gundel; Nadine Schulte; Ulrike Spaniol; Carolin Pflueger; Eugen Zizer; Georg B T von Boyen
Journal:  BMC Gastroenterol       Date:  2012-01-17       Impact factor: 3.067

View more
  13 in total

Review 1.  Neurons and Glia in the Enteric Nervous System and Epithelial Barrier Function.

Authors:  Nathalie Vergnolle; Carla Cirillo
Journal:  Physiology (Bethesda)       Date:  2018-07-01

Review 2.  Immunopathological and molecular basis of functional dyspepsia and current therapeutic approaches.

Authors:  Mounika Addula; Victoria E D Wilson; Savio Reddymasu; Devendra K Agrawal
Journal:  Expert Rev Clin Immunol       Date:  2018-09-29       Impact factor: 4.473

3.  Central nervous system stimulants promote nerve cell death under continuous hypoxia.

Authors:  Kei Ikeda-Murakami; Tomoya Ikeda; Miho Watanabe; Naoto Tani; Takaki Ishikawa
Journal:  Hum Cell       Date:  2022-06-23       Impact factor: 4.374

4.  Exosomal hsa-miR-933 in Gastric Juice as a Potential Biomarker for Functional Dyspepsia.

Authors:  Fumio Tanaka; Shingo Takashima; Yuji Nadatani; Koji Otani; Shuhei Hosomi; Noriko Kamata; Koichi Taira; Yasuaki Nagami; Tetsuya Tanigawa; Shinya Fukumoto; Toshio Watanabe; Yoshiki Murakami; Norifumi Kawada; Yasuhiro Fujiwara
Journal:  Dig Dis Sci       Date:  2020-01-23       Impact factor: 3.199

Review 5.  Immune Activation in Functional Dyspepsia: Bystander Becoming the Suspect.

Authors:  Matthias Ceulemans; Inge Jacobs; Lucas Wauters; Tim Vanuytsel
Journal:  Front Neurosci       Date:  2022-04-26       Impact factor: 5.152

Review 6.  Recent understanding of the pathophysiology of functional dyspepsia: role of the duodenum as the pathogenic center.

Authors:  Hiroto Miwa; Tadayuki Oshima; Toshihiko Tomita; Hirokazu Fukui; Takashi Kondo; Takahisa Yamasaki; Jiro Watari
Journal:  J Gastroenterol       Date:  2019-02-14       Impact factor: 7.527

Review 7.  Gastroparesis and Functional Dyspepsia: A Blurring Distinction of Pathophysiology and Treatment.

Authors:  Beom Jin Kim; Braden Kuo
Journal:  J Neurogastroenterol Motil       Date:  2019-01-31       Impact factor: 4.924

Review 8.  Revisiting the Role of Neurotrophic Factors in Inflammation.

Authors:  Lucas Morel; Olivia Domingues; Jacques Zimmer; Tatiana Michel
Journal:  Cells       Date:  2020-04-02       Impact factor: 6.600

9.  Paeoniflorin Alleviates Abnormalities in Rats with Functional Dyspepsia by Stimulating the Release of Acetylcholine.

Authors:  Xuan Zou; Yang Wang; Yuheng Wang; Junting Yang; Huishu Guo; Zhengxu Cai
Journal:  Drug Des Devel Ther       Date:  2020-12-22       Impact factor: 4.162

10.  Sini-san improves duodenal tight junction integrity in a rat model of functional dyspepsia.

Authors:  Xiongfei Chang; Luqing Zhao; Jiajia Wang; Xiaofang Lu; Shengsheng Zhang
Journal:  BMC Complement Altern Med       Date:  2017-08-30       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.